Drug Shortage Report for MYLAN-AMLODIPINE

Last updated on 2018-02-10 History
Report ID 28029
Drug Identification Number 02272121
Brand name MYLAN-AMLODIPINE
Common or Proper name AMLODIPINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) AMLODIPINE
Strength(s) 10.0MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100BT, 500BT
ATC code C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-01-31
Actual start date 2018-01-31
Estimated end date 2018-02-09
Actual end date 2018-02-09
Shortage status Resolved
Updated date 2018-02-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2018-01-15 English Compare
v25 2017-12-01 English Compare
v24 2017-11-30 French Compare
v23 2017-11-30 English Compare
v22 2017-11-27 French Compare
v21 2017-11-27 English Compare
v20 2017-11-24 French Compare
v19 2017-11-24 English Compare
v18 2017-11-23 French Compare
v17 2017-11-23 English Compare
v16 2017-11-22 French Compare
v15 2017-11-22 English Compare
v14 2017-11-20 French Compare
v13 2017-11-20 English Compare
v12 2017-11-16 French Compare
v11 2017-11-16 English Compare
v10 2017-11-15 French Compare
v9 2017-11-15 English Compare
v8 2017-11-10 French Compare
v7 2017-11-10 English Compare

Showing 21 to 40 of 46